{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T07:36:34Z","timestamp":1768462594757,"version":"3.49.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T00:00:00Z","timestamp":1684281600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T00:00:00Z","timestamp":1684281600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Takeda Development Center Americas, Inc."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Ther"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s40120-023-00479-4","type":"journal-article","created":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T04:01:43Z","timestamp":1684296103000},"page":"1171-1186","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Intravenous Immunoglobulin Initiation in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A US Claims-based Cohort Study"],"prefix":"10.1007","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0994-5820","authenticated-orcid":false,"given":"J. Bradley","family":"Layton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0304-9304","authenticated-orcid":false,"given":"Mary E.","family":"Ritchey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongwen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shailesh","family":"Chavan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hakan","family":"Ay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3873-3448","authenticated-orcid":false,"given":"Nizar","family":"Souayah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2734-6154","authenticated-orcid":false,"given":"Colin","family":"Anderson-Smits","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,17]]},"reference":[{"issue":"3","key":"479_CR1","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1111\/j.1085-9489.2005.10311.x","volume":"10","author":"S Boukhris","year":"2005","unstructured":"Boukhris S, Magy L, Gallouedec G, Khalil M, Couratier P, Gil J, et al. Fatigue as the main presenting symptom of chronic inflammatory demyelinating polyradiculoneuropathy: a study of 11 cases. J Peripher Nerv Syst. 2005;10(3):329\u201337. https:\/\/doi.org\/10.1111\/j.1085-9489.2005.10311.x.","journal-title":"J Peripher Nerv Syst"},{"issue":"1","key":"479_CR2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/mus.24109","volume":"50","author":"JT Guptill","year":"2014","unstructured":"Guptill JT, Bromberg MB, Zhu L, Sharma BK, Thompson AR, Krueger A, et al. Patient demographics and health plan paid costs in chronic inflammatory demyelinating polyneuropathy. Muscle Nerve. 2014;50(1):47\u201351. https:\/\/doi.org\/10.1002\/mus.24109.","journal-title":"Muscle Nerve"},{"issue":"3\u20134","key":"479_CR3","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1159\/000445347","volume":"75","author":"IS Merkies","year":"2016","unstructured":"Merkies IS, Kieseier BC. Fatigue, pain, anxiety and depression in Guillain-Barr\u00e9 syndrome and chronic inflammatory demyelinating polyradiculoneuropathy. Eur Neurol. 2016;75(3\u20134):199\u2013206. https:\/\/doi.org\/10.1159\/000445347.","journal-title":"Eur Neurol"},{"issue":"9","key":"479_CR4","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1080\/09638280802306497","volume":"31","author":"ME Westblad","year":"2009","unstructured":"Westblad ME, Forsberg A, Press R. Disability and health status in patients with chronic inflammatory demyelinating polyneuropathy. Disabil Rehabil. 2009;31(9):720\u20135. https:\/\/doi.org\/10.1080\/09638280802306497.","journal-title":"Disabil Rehabil"},{"issue":"10","key":"479_CR5","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1136\/jnnp-2020-323615","volume":"91","author":"PE Doneddu","year":"2020","unstructured":"Doneddu PE, Cocito D, Manganelli F, Fazio R, Briani C, Filosto M, et al. Frequency of diabetes and other comorbidities in chronic inflammatory demyelinating polyradiculoneuropathy and their impact on clinical presentation and response to therapy. J Neurol Neurosurg Psychiatry. 2020;91(10):1092\u20139.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"479_CR6","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s40120-020-00184-6","volume":"9","author":"JA Allen","year":"2020","unstructured":"Allen JA. The misdiagnosis of CIDP: a review. Neurol Ther. 2020;9:43\u201354.","journal-title":"Neurol Ther"},{"key":"479_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-10-5361-0_38","author":"SV Khadilkar","year":"2018","unstructured":"Khadilkar SV, Yadav RS, Patel BA, Khadilkar SV, Yadav RS, Patel BA. Chronic inflammatory demyelinating polyradiculoneuropathy. Neuromusc Disord. 2018. https:\/\/doi.org\/10.1007\/978-981-10-5361-0_38.","journal-title":"Neuromusc Disord"},{"issue":"3","key":"479_CR8","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1111\/jns.12455","volume":"26","author":"PYK Van den Bergh","year":"2021","unstructured":"Van den Bergh PYK, van Doorn PA, Hadden RDM, Avau B, Vankrunkelsven P, Allen JA, et al. European Academy of Neurology\/Peripheral Nerve Society Guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint Task Force\u2014second revision. J Peripher Nerv Syst. 2021;26(3):242\u201368. https:\/\/doi.org\/10.1111\/jns.12455.","journal-title":"J Peripher Nerv Syst"},{"issue":"11","key":"479_CR9","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1093\/brain\/awaa265","volume":"143","author":"F Eftimov","year":"2020","unstructured":"Eftimov F, Lucke IM, Querol LA, Rajabally YA, Verhamme C. Diagnostic challenges in chronic inflammatory demyelinating polyradiculoneuropathy. Brain. 2020;143(11):3214\u201324.","journal-title":"Brain"},{"issue":"10","key":"479_CR10","doi-asserted-by":"publisher","first-page":"3706","DOI":"10.1007\/s00415-020-09998-8","volume":"268","author":"L Querol","year":"2020","unstructured":"Querol L, Crabtree M, Herepath M, Priedane E, Viejo Viejo I, Agush S, et al. Systematic literature review of burden of illness in chronic inflammatory demyelinating polyneuropathy (CIDP). J Neurol. 2020;268(10):3706\u201316. https:\/\/doi.org\/10.1007\/s00415-020-09998-8.","journal-title":"J Neurol"},{"issue":"12","key":"479_CR11","first-page":"32","volume":"99","author":"J Reynolds","year":"2016","unstructured":"Reynolds J, George Sachs M, Stavros K. Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): clinical features, diagnosis, and current treatment strategies. R I Med J. 2016;99(12):32.","journal-title":"R I Med J"},{"issue":"3\u20134","key":"479_CR12","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1159\/000494291","volume":"52","author":"MC Broers","year":"2019","unstructured":"Broers MC, Bunschoten C, Nieboer D, Lingsma HF, Jacobs BC. Incidence and prevalence of chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review and meta-analysis. Neuroepidemiology. 2019;52(3\u20134):161\u201372. https:\/\/doi.org\/10.1159\/000494291.","journal-title":"Neuroepidemiology"},{"issue":"1","key":"479_CR13","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1212\/WNL.0b013e3181aaea47","volume":"73","author":"RS Laughlin","year":"2009","unstructured":"Laughlin RS, Dyck PJ, Melton LJ 3rd, Leibson C, Ransom J, Dyck PJ. Incidence and prevalence of CIDP and the association of diabetes mellitus. Neurology. 2009;73(1):39\u201345. https:\/\/doi.org\/10.1212\/WNL.0b013e3181aaea47.","journal-title":"Neurology"},{"issue":"10","key":"479_CR14","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1586\/14737175.6.10.1545","volume":"6","author":"YC Chan","year":"2006","unstructured":"Chan YC, Wilder-Smith E. Predicting treatment response in chronic, acquired demyelinating neuropathies. Expert Rev Neurother. 2006;6(10):1545\u201353. https:\/\/doi.org\/10.1586\/14737175.6.10.1545.","journal-title":"Expert Rev Neurother"},{"issue":"6","key":"479_CR15","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1212\/WNL.0000000000001833","volume":"85","author":"JA Allen","year":"2015","unstructured":"Allen JA, Lewis RA. CIDP diagnostic pitfalls and perception of treatment benefit. Neurology. 2015;85(6):498\u2013504. https:\/\/doi.org\/10.1212\/WNL.0000000000001833.","journal-title":"Neurology"},{"issue":"3","key":"479_CR16","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/jns.12344","volume":"24","author":"C Bunschoten","year":"2019","unstructured":"Bunschoten C, Blomkwist-Markens PH, Horemans A, van Doorn PA, Jacobs BC. Clinical factors, diagnostic delay, and residual deficits in chronic inflammatory demyelinating polyradiculoneuropathy. J Peripher Nerv Syst. 2019;24(3):253\u20139. https:\/\/doi.org\/10.1111\/jns.12344.","journal-title":"J Peripher Nerv Syst"},{"issue":"6","key":"479_CR17","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1097\/ACI.0000000000000696","volume":"20","author":"J Prevot","year":"2020","unstructured":"Prevot J, Jolles S. Global immunoglobulin supply: steaming towards the iceberg? Curr Opin Allergy Clin Immunol. 2020;20(6):557.","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"479_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2022.108931","volume":"236","author":"JT Anderson","year":"2022","unstructured":"Anderson JT, Cowan J, Condino-Neto A, Levy D, Prusty S. Health-related quality of life in primary immunodeficiencies: impact of delayed diagnosis and treatment burden. Clin Immunol. 2022;236: 108931.","journal-title":"Clin Immunol"},{"key":"479_CR19","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1007\/s12325-020-01540-6","volume":"38","author":"JA Allen","year":"2021","unstructured":"Allen JA, Butler L, Levine T, Haudrich A. A global survey of disease burden in patients who carry a diagnosis of chronic inflammatory demyelinating polyneuropathy. Adv Ther. 2021;38:316\u201328.","journal-title":"Adv Ther"},{"issue":"10","key":"479_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0206205","volume":"13","author":"V Divino","year":"2018","unstructured":"Divino V, Mallick R, DeKoven M, Krishnarajah G. The economic burden of CIDP in the United States: a case-control study. PLoS\u00a0One. 2018;13(10): e0206205.","journal-title":"PLoS\u00a0One"},{"key":"479_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.645263","volume":"12","author":"RK Burt","year":"2021","unstructured":"Burt RK, Tappenden P, Balabanov R, Han X, Quigley K, Snowden JA, et al. The cost effectiveness of immunoglobulin vs. hematopoietic stem cell transplantation for CIDP. Front Neurol. 2021;12: 645263.","journal-title":"Front Neurol"},{"key":"479_CR22","unstructured":"Thomas S, Chirila C, Ritchey M. Visualization of patient electronic records to support exploratory analysis and variable derivation of categorical data. In: 25th Annual Southeast SASI Users Group (SESUG) Conference. Cary, NC; 2017."},{"issue":"5","key":"479_CR23","first-page":"604","volume":"6","author":"MA Brookhart","year":"2013","unstructured":"Brookhart MA, Wyss R, Layton JB, St\u00fcrmer T. Propensity score methods for confounding control in nonexperimental research. Circulation. 2013;6(5):604\u201311.","journal-title":"Circulation"},{"issue":"3","key":"479_CR24","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/j.1468-1331.2009.02930.x","volume":"17","author":"PY Van den Bergh","year":"2010","unstructured":"Van den Bergh PY, Hadden RD, Bouche P, Cornblath DR, Hahn A, Illa I, et al. European Federation of Neurological Societies\/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society\u2014first revision. Eur J Neurol. 2010;17(3):356\u201363. https:\/\/doi.org\/10.1111\/j.1468-1331.2009.02930.x.","journal-title":"Eur J Neurol"},{"key":"479_CR25","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jns.2018.11.031","volume":"397","author":"D Gelinas","year":"2019","unstructured":"Gelinas D, Katz J, Nisbet P, England JD. Current practice patterns in CIDP: a cross-sectional survey of neurologists in the United States. J Neurol Sci. 2019;397:84\u201391. https:\/\/doi.org\/10.1016\/j.jns.2018.11.031.","journal-title":"J Neurol Sci"},{"issue":"3","key":"479_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.932","volume":"8","author":"JA Allen","year":"2018","unstructured":"Allen JA, Gorson KC, Gelinas D. Challenges in the diagnosis of chronic inflammatory demyelinating polyneuropathy. Brain Behav. 2018;8(3): e00932. https:\/\/doi.org\/10.1002\/brb3.932.","journal-title":"Brain Behav"},{"issue":"1","key":"479_CR27","doi-asserted-by":"publisher","first-page":"7910","DOI":"10.1038\/s41598-020-64699-6","volume":"10","author":"L Gentile","year":"2020","unstructured":"Gentile L, Mazzeo A, Russo M, Arimatea I, Vita G, Toscano A. Long-term treatment with subcutaneous immunoglobulin in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a follow-up period up to 7 years. Sci Rep. 2020;10(1):7910. https:\/\/doi.org\/10.1038\/s41598-020-64699-6.","journal-title":"Sci Rep"},{"issue":"1","key":"479_CR28","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1177\/1756285614563056","volume":"8","author":"RD Hadden","year":"2015","unstructured":"Hadden RD, Marreno F. Switch from intravenous to subcutaneous immunoglobulin in CIDP and MMN: improved tolerability and patient satisfaction. Ther Adv Neurol Disord. 2015;8(1):14\u20139. https:\/\/doi.org\/10.1177\/1756285614563056.","journal-title":"Ther Adv Neurol Disord"}],"container-title":["Neurology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-023-00479-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40120-023-00479-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-023-00479-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T17:09:37Z","timestamp":1700154577000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40120-023-00479-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,17]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["479"],"URL":"https:\/\/doi.org\/10.1007\/s40120-023-00479-4","relation":{},"ISSN":["2193-8253","2193-6536"],"issn-type":[{"value":"2193-8253","type":"print"},{"value":"2193-6536","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,17]]},"assertion":[{"value":"23 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}